Zolmitriptan Synthesis via Sodium Bisulfite Reduction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The existing methods for synthesizing zolmitriptan face challenges such as the use of environmentally undesirable tin salts, poor solubility of reagents leading to heterogeneous reactions, prolonged reaction times, high energy consumption, and inefficient solvent usage, resulting in low yield and increased environmental impact.
Innovation Solution
The method involves optimizing the reduction stage using alkali metal disulphite as a reduction agent and isolating zolmitriptan as a toluene solvate, which reduces reaction time, energy consumption, and solvent usage, and allows for efficient purification and desolvation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If stannous chloride is used as reduction reagent, then reduction reaction proceeds effectively, but purification becomes difficult and environmentally undesirable tin salts are generated
Solution Approach 1:
The patent replaces stannous chloride with sodium bisulfite, a cheaper and environmentally benign reducing agent that generates soluble sodium sulfate and sulfur dioxide instead of harmful tin salts, eliminating purification difficulties and environmental concerns while maintaining effective reduction of the diazonium salt to the hydrazine intermediate
2Object-generated harmful factors
If Na2SO3 is used as reduction reagent, then environmentally friendly reduction is achieved, but solubility is poor leading to heterogeneous reaction system
Solution Approach 1:
The patent changes the chemical parameter from sodium sulfite to sodium bisulfite, which has significantly improved water solubility. This allows the reduction reaction to proceed in a homogeneous aqueous solution, eliminating stirring problems associated with heterogeneous systems while maintaining environmental friendliness and avoiding tin salt contamination
3Stability of the object's composition
If reaction mixture is strongly diluted to improve solubility, then homogeneous reaction system is achieved, but reaction time increases substantially
Solution Approach 1:
By changing the reducing agent from sodium sulfite to sodium bisulfite, the patent achieves both high solubility and acceptable reaction concentration. The improved solubility of sodium bisulfite allows the reaction to proceed in a homogeneous system without requiring strong dilution, thus maintaining reaction time of 12-18 hours rather than extending it further
4Quantity of substance
If repeated extraction with ethyl acetate is used for isolation, then product recovery is achieved, but considerable volumes of solvent and energy are required
Solution Approach 1:
The patent utilizes the phase transition of zolmitriptan from soluble to insoluble form by adjusting pH to 2-3 with hydrochloric acid, causing the product to precipitate directly from the aqueous reaction mixture. This eliminates the need for repeated extractions with large volumes of ethyl acetate and subsequent evaporation, significantly reducing solvent consumption and energy requirements
Solution Approach 2:
Instead of extracting the product from the aqueous phase using organic solvents, the patent directly precipitates the product by pH adjustment and filters it off. This taking out approach removes the need for solvent-intensive extraction and concentration steps, reducing both solvent usage and energy consumption for evaporation
5Quantity of substance
If concentration of extracts is performed to reduce volume, then crystalline product is obtained, but product is subject to considerable heat load
Solution Approach 1:
The patent eliminates the concentration step entirely by directly precipitating the product from the aqueous reaction mixture through pH adjustment. The product is filtered off in its crystalline form without requiring evaporation of large volumes of solvent, thus avoiding the considerable heat load that would be applied to the product during concentration
6Ease of manufacture
If alkaline aqueous environment is used during extractions, then product isolation is facilitated, but hydrolysis of product and solvent occurs
Solution Approach 1:
Instead of using an alkaline environment to facilitate isolation, the patent inverts the approach by using an acidic environment (pH 2-3) to precipitate the product. This inversion avoids the hydrolysis problems associated with alkaline conditions while still achieving effective product isolation through direct precipitation and filtration
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly reduces reaction time, energy consumption, and environmental impact while improving yield and product quality, using fewer solvents and minimizing heat load, thus addressing the limitations of previous methods.
Implementation Method 1
a salt, e.g. chloride, of (S)-4-(4-benzyldiazonium)-1,3-oxazolidin-2-one is reduced in an aqueous solution to (S)-4-(4-hydrazinobenzyl)-1,3-oxazolidin-2-one by the effect of an alkali metal disulphite
Implementation Method 2
isolation of the raw toluene solvate of zolmitriptan as an intermediate product
Data Source
AI summary
In the preparation of zolmitriptan of formula III the reduction of the diazonium salt to (5)-4-(4-hydrazinobenzyl)-1,3-oxazolidin-2-one of formula IV is performed in a more concentrated mixture and by the effect on an alkali metal disulphite, preferably sodium disulphite. A zolmitriptan toluene solvate, characterized by a toluene content of 9 to 14% by weight according to the gas chromatography determination and by a maximum of the corresponding mass loss at temperatures of about 111° C. in the gravimetric analysis record. A zolmitriptan toluene solvate, showing strong Raman bands at the wave numbers of 1443 and 1354 cm−1, characteristic for the crystal lattice of zolmitriptan with built-in toluene, and further marked bands at 1004 and 786 cm−1, characteristic for toluene.